GSK Boosted by New Vaccines 0 29.07.2015 17:58 WSJ.com GlaxoSmithKline reported a 6% rise in second-quarter revenue to $9.19 billion, boosted by new vaccines and consumer health-care products from its $20 billion asset swap with Novartis. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
